Worst case scenario: wouldn't the scientific paper
Post# of 36537
Even if Generex is the last COVID-19 play out there, and doesn't sell a unit of that vaccine because they were the last to finish, wouldn't having a published scientific paper with the safety and efficacy pay dividends for COVID-21, etc? Having results posted in a reputable journal, peered reviewed, etc. Funding would come a hell of a lot quicker than this.